Paterna BioSciences
We have a serious commitment to solving Infertility.
We know what healthy sperm looks like from stem cell to healthy sperm – that’s why we’re going to solve infertility first.
Paterna has built the pillars for business success in in vitro spermatogenesis.
We’re making infertility history.
By partnering with IVF clinics to improve IVF success rates and offer personalized male fertility diagnosis and treatment.
By engaging men in optimizing their reproductive and offspring health.
By reducing heritable diseases passed through the human germline via diagnostics.
By expanding the market for IVF and facilitate IUI for couples.
Learn about the science >>
Executive Summary.
Who are we?
Paterna Biosciences is focused on creating the equivalent of Male IVF, a “blue ocean” opportunity by growing healthy sperm in a dish (in vitro spermatogenesis).
What can/will we achieve?
In vitro spermatogenesis will fundamentally alter the reproductive paradigm, improve human health, and put the care of male infertility on par with female fertility.
Who’s on our team?
We have a world-class team that has been working together for 10+ years, making groundbreaking progress.
The big picture
We have patented the process to use chaperoned machine learning techniques with single-cell RNA sequencing from over 200 archived healthy human testis samples to iteratively refine and test culturing techniques to achieve lab-based spermatogenesis in the near future.
No one has solved the problem or taken our successful approach.
Reach out to us to learn more.
The best of fertility, biotech, and business experience.
Our Experienced Team.
We’re the leading experts in infertility.
We’ve secured ~$50M in NIH and HHMI funding.
Read all team bios >>
Alex Pastuszak
Chief Executive Officer
Jim Hotaling
Co-founder and Chief Medical Officer
Brad Cairns
Co-founder and Chair of Scientific Advisors
Jingtao Guo
Co-founder and Bioinformatics Consultant
Hollie Chan
Chief of Staff
Kyle Orwig
Co-founder and Scientific Advisor
Danny Mitchell
Chief Financial Officer
Xichen Nie
Scientific Manager Designate
The Board.
Read all board member bios >>
Antonio Pellicer
CEO, IVI-RMA Global Founder “Instituto Valenciano de Infertilidad” (“IVI”)
Cynthia Tsai
CEO of Healthquest, a Global Biotechnology and Medical Technologies Advisory Firm
Deirdre Conway
Intermountain Healthcare Practice Director Utah Fertility Center
Jim Hotaling
Chief Medical Officer & Co-Chairman Paterna Biosciences Inc.
Board Observers.
Carlos Blanes
Former Deputy CEO, IVI-RMA Global
Marc Entrecanales
CFO, IVI-RMA
Francisco Jiménez
The Advisors.
Read all advisor bios >>
Donald F. Conrad, Ph.D.
Chief, Division of Genetics, Oregon National Primate Research Center. Associate Professor, Oregon National Primate Research Center
Specialty
Leading research in testis biology: developing methods for multiplex in vivo functional characterization of genes in testicular germ cells using shRNA and CRISPR and purifying testicular cell populations. Pioneering work in genome-scale analysis of DNA copy number variation (CNV).
Kenneth “Ki” Ivan Aston
Adjunct Associate Professor, Obstetrics And Gynecology & Associate Professor, Surgery, the University of Utah
Specialty
Identifying genetic and epigenetic factors associated with male infertility. In addition, expanding fertility preservation options.
David Bearss
CEO Halia Therapeutics
Specialty
Peter Thurlow
Chair, IP Medical Device Group at Polsinelli LLP
Specialty
Intellectual Property
Amy Divaraniya
CEO & Founder at OOVA, Inc.
Specialty
Entrepreneurship in the fertility field, working with academic hospitals, integrating technology into medical practice.